Columbia Seligman (NYSE: STK) schedules 16th annual stockholder meeting for 2026

Rhea-AI Filing Summary

Columbia Seligman Premium Technology Growth Fund, Inc. has scheduled its 16th Annual Meeting of Stockholders for June 16, 2026, in Minneapolis, Minnesota. Stockholders of record at the close of business on April 21, 2026 will be entitled to receive notice and vote.

At the meeting, stockholders will be asked to elect four directors to serve until the 2029 Annual Meeting, ratify the selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for the 2026 fiscal year, and consider any other proper business. Further details will be provided in a proxy statement to be filed with the SEC.

0001471420 false 0001471420 2026-03-19 2026-03-19

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 19, 2026

Columbia Seligman Premium Technology Growth Fund, Inc.

(Exact name of registrant as specified in its charter)

Maryland		811-22328		20-0994125
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

290 Congress Street, Boston, Massachusetts		02210
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (800)-937-5449

NOT APPLICABLE

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		STK		The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company		☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.		☐

SECTION 7 — REGULATION FD

Item 7.01 Regulation FD Disclosure.

Registrant is furnishing as Exhibit 99.1 the attached Press Release dated March 19, 2026 for Columbia Seligman Premium Technology Growth Fund, Inc.

2

Exhibit Index

Exhibit No.		Description
99.1		Press Release

3

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 19, 2026

COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC.
By:		/s/ Joseph D’Alessandro
		Joseph D’Alessandro
		Vice President and Assistant Secretary

4

Exhibit EX99_1

Stockholder contact:    salesinquiries@columbiathreadneedle.com

Media contact:       Meghan Shields meghan.shields@columbiathreadneedle.com

COLUMBIA SELIGMAN PREMIUM TECHNOLOGY GROWTH FUND, INC.

ANNOUNCEMENTS REGARDING

16^th ANNUAL MEETING OF STOCKHOLDERS

Boston, MA, March 19, 2026 — The Board of Directors (the Board) of Columbia Seligman Premium Technology Growth Fund, Inc. (the Fund) (NYSE: STK) today announced that the Fund’s 16^th Annual Meeting of Stockholders will be held on June 16, 2026 (the Meeting) in Minneapolis, MN. The close of business on April 21, 2026 has been fixed by the Fund’s Board as the record date for the determination of Stockholders entitled to notice of, and to vote at, the Meeting or any postponement or adjournment thereof.

At the Meeting, Stockholders will be asked to elect four directors, Messrs. Brian J. Gallagher and Ryan C. Larrenaga and Mses. Nancy T. Lukitsh and Catherine James Paglia, to the Board, each to hold office until the 2029 Annual Meeting of Stockholders, and all until their successors are elected and qualify; to consider the ratification of the Board’s selection of PricewaterhouseCoopers LLP as the Fund’s independent registered public accounting firm for the 2026 fiscal year; and to consider such other matters as may properly come before the Meeting or any postponement or adjournment thereof. This and other information relating to the Meeting, including additional details of the Meeting time and how to access the Meeting, will be described in a notice of meeting and proxy statement that the Fund intends to file with the Securities and Exchange Commission.

Columbia Threadneedle Investments^® (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.

The Fund is managed by Columbia Management Investment Advisers, LLC.

Investors should consider the investment objectives, risks, charges, and expenses of the Fund carefully before investing. A prospectus containing information about the Fund (including its investment objectives, risks, charges, expenses, and other information about the Fund) may be obtained by contacting your financial advisor or visiting columbiathreadneedleus.com. The prospectus should be read carefully before investing in the Fund. For more information, please visit columbiathreadneedleus.com.

Investment products are not insured by the FDIC, NCUA or any federal agency, are not deposits or obligations of, or guaranteed by any financial institution, and involve investment risks including possible loss of principal and fluctuation in value.

^© 2026 Columbia Threadneedle. All rights reserved.

Adtrax: [CTNA8798752.1-]

FAQ

When is Columbia Seligman Premium Technology Growth Fund (STK) holding its 2026 annual stockholder meeting?

The Fund’s 16th Annual Meeting of Stockholders is scheduled for June 16, 2026, in Minneapolis, Minnesota. The meeting will cover director elections, auditor ratification, and any other proper business, with full details to be provided in a forthcoming proxy statement.

What is the record date for voting at Columbia Seligman Premium Technology Growth Fund’s 2026 annual meeting?

The record date is the close of business on April 21, 2026. Only stockholders of record on that date will be entitled to receive notice of, and vote at, the June 16, 2026 Annual Meeting and any postponements or adjournments.

What proposals will STK stockholders vote on at the 2026 annual meeting?

Stockholders will vote on electing four directors to the Board to serve until the 2029 Annual Meeting and on ratifying PricewaterhouseCoopers LLP as independent registered public accounting firm for the 2026 fiscal year, plus any other matters properly brought before the meeting.

Which director nominees are up for election at Columbia Seligman Premium Technology Growth Fund’s 2026 meeting?

The nominees are Messrs. Brian J. Gallagher and Ryan C. Larrenaga and Mses. Nancy T. Lukitsh and Catherine James Paglia. Each is proposed to serve on the Board until the 2029 Annual Meeting of Stockholders and until a successor is elected and qualifies.

Who has been selected as STK’s independent registered public accounting firm for 2026?

The Board has selected PricewaterhouseCoopers LLP as the Fund’s independent registered public accounting firm for the 2026 fiscal year. Stockholders will be asked to consider ratifying this selection at the June 16, 2026 Annual Meeting in Minneapolis.

Where can investors find more information about Columbia Seligman Premium Technology Growth Fund (STK) and the 2026 meeting?

Further details on the meeting, including time and access information, will appear in a proxy statement filed with the SEC. Investors can also review the Fund’s prospectus and other materials at columbiathreadneedleus.com or by contacting their financial advisor.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 5.6 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 2.4 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 16.8 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 10.5 KB